Poltreg poltreg.tech


Poltreg aims to commercialize the TREG Method. The TREG method is a therapy with the use of T-regulatory lymphocytes, taken from the patient's blood, currently used to treat type 1 diabetes in children.

Poltreg aims to commercialize the TREG Method. The TREG method is a therapy with the use of T-regulatory lymphocytes, taken from the patient's blood, currently used to treat type 1 diabetes in children.

Company (Alive / Active)

Phone:

Fax:

ul. Trzy Lipy 3

Gdansk, 80-172
Poland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Poltreg $0M May 23, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Poltreg Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)